Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ROS1 translocations and amplifications in lung cancer brain metastases.

Literature DB >> 24760415

ROS1 translocations and amplifications in lung cancer brain metastases.

Matthias Preusser¹, Berthold Streubel², Peter Birner^2,3.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2014 PMID： 24760415 DOI： 10.1007/s11060-014-1446-x

Source DB: PubMed Journal: J Neurooncol ISSN： 0167-594X Impact factor: 4.130

× No keyword cloud information.

3 in total

1. ROS1 rearrangements define a unique molecular class of lung cancers.

Authors: Kristin Bergethon; Alice T Shaw; Sai-Hong Ignatius Ou; Ryohei Katayama; Christine M Lovly; Nerina T McDonald; Pierre P Massion; Christina Siwak-Tapp; Adriana Gonzalez; Rong Fang; Eugene J Mark; Julie M Batten; Haiquan Chen; Keith D Wilner; Eunice L Kwak; Jeffrey W Clark; David P Carbone; Hongbin Ji; Jeffrey A Engelman; Mari Mino-Kenudson; William Pao; A John Iafrate
Journal: J Clin Oncol Date: 2012-01-03 Impact factor: 44.544

2. ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.

Authors: Matthias Preusser; Anna S Berghoff; Ayseguel Ilhan-Mutlu; Manuel Magerle; Carina Dinhof; Georg Widhalm; Karin Dieckmann; Christine Marosi; Adelheid Wöhrer; Monika Hackl; Sabine Zöchbauer-Müller; Andreas von Deimling; Sebastian F Schoppmann; Christoph C Zielinski; Berthold Streubel; Peter Birner
Journal: Lung Cancer Date: 2013-02-27 Impact factor: 5.705

ROS1 translocations and amplifications in lung cancer brain metastases.

1. ROS1 rearrangements define a unique molecular class of lung cancers.

2. ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.

Review 3. Molecular pathways: ROS1 fusion proteins in cancer.

1. Hippocampal Metastasis Rate Based on Non-Small Lung Cancer TNM Stage and Molecular Markers.

Review 2. Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

Review 3. Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment.